Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 43 contracts
Sources: Securities Purchase Agreement (Odyssey Group International, Inc.), Securities Purchase Agreement (Odyssey Group International, Inc.), Common Stock Purchase Warrant (Pacific Ventures Group, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.999.9% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 5 contracts
Sources: Common Stock Purchase Warrant (Fomo Corp.), Warrant Agreement (Jerrick Media Holdings, Inc.), Common Stock Purchase Warrant (Gopher Protocol Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder▇▇▇▇▇▇, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 4 contracts
Sources: Common Stock Purchase Warrant (iCoreConnect Inc.), Common Stock Purchase Warrant (iCoreConnect Inc.), Common Stock Purchase Warrant (iCoreConnect Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 3 contracts
Sources: Common Stock Purchase Warrant (iCoreConnect Inc.), Common Stock Purchase Warrant (iCoreConnect Inc.), Common Stock Purchase Warrant (iCoreConnect Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of HolderH▇▇▇▇▇, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 3 contracts
Sources: Common Stock Purchase Warrant (BioCorRx Inc.), Common Stock Purchase Warrant (BioCorRx Inc.), Security Agreement (Blockchain Industries, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.999.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 3 contracts
Sources: Common Stock Purchase Warrant (Activecare, Inc.), Common Stock Purchase Warrant (Blue Sphere Corp.), Common Stock Purchase Warrant (Duos Technologies Group, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four two (242) hours business days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 2 contracts
Sources: Common Stock Purchase Warrant (Adhera Therapeutics, Inc.), Common Stock Purchase Warrant (Adhera Therapeutics, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder▇▇▇▇▇▇, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 2 contracts
Sources: Common Stock Purchase Warrant (iCoreConnect Inc.), Common Stock Purchase Warrant (iCoreConnect Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.999.99% of the Common Stock outstanding of the Company (the “"Beneficial Ownership Limitation”"). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 2 contracts
Sources: Common Stock Purchase Warrant (Activecare, Inc.), Common Stock Purchase Warrant (Activecare, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.999.9% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four two (242) hours business days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 2 contracts
Sources: Common Stock Purchase Warrant (Fomo Corp.), Common Stock Purchase Warrant (Adhera Therapeutics, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of HolderH▇▇▇▇▇, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “"Beneficial Ownership Limitation”"). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Sources: Common Stock Purchase Warrant (HDS International Corp.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of HolderHo▇▇▇▇, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.994.9% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). This provision may not be waived except upon not less than 61 days’ notice from the Holder to the Company. Upon the written or oral request of HolderH▇▇▇▇▇, the Company shall within twenty-four (24) hours one Business Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.999.9% of the Common Stock outstanding of the Company (the “Beneficial Ownership Limitation”). Upon the written or oral request of Holder▇▇▇▇▇▇, the Company shall within twenty-four two (242) hours business days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract
Sources: Common Stock Purchase Warrant (Freedom Holdings, Inc.)
Holder’s Exercise Limitations. Unless otherwise agreed in writing by both the Company and the Holder, at no time will the Holder exercise any amount of this Warrant to purchase Common Stock that would result in the Holder owning more than 4.99% of the Common Stock outstanding of the Company (the “"Beneficial Ownership Limitation”Limitation "). Upon the written or oral request of Holder, the Company shall within twenty-four (24) hours confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
Appears in 1 contract